219311-44-1 | Dabuzalgron

Packsize	Purity	Availability	Price	Discounted Price
1mg	95%	in stock	$48.00	$33.00
5mg	95%	in stock	$129.00	$90.00
10mg	95%	in stock	$216.00	$151.00
25mg	95%	in stock	$270.00	$189.00
100mg	95%	in stock	$606.00	$424.00
250mg	95%	in stock	$1,172.00	$820.00

Description

• Catalog Number: AB45838
• Chemical Name: Dabuzalgron
• CAS Number: 219311-44-1
• Molecular Formula: C12H16ClN3O3S
• Molecular Weight: 317.7917
• MDL Number: MFCD13195546
• SMILES: Clc1ccc(c(c1NS(=O)(=O)C)C)OCC1=NCCN1

Computed Properties

• Complexity: 463
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 20
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 5
• XLogP3: 0.9

Upstream Synthesis Route

N-[6-chloro-3-(4,5-dihydro-1H-imidazol-2-ylmethoxy)-2-methylphenyl]methanesulfonamide is a versatile compound widely utilized in chemical synthesis. It serves as a key building block in the creation of various pharmaceuticals, agrochemicals, and specialty chemicals. Due to its unique structural features, this compound plays a crucial role in the development of novel drug candidates and biologically active molecules. In addition, its sulfonamide group enables efficient derivatization, further expanding its application scope in synthetic organic chemistry. This compound's precise control over regioselectivity and stereochemistry makes it a valuable tool for chemists in designing and producing complex molecular structures with high efficiency and selectivity.

Literature

• Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function.

  The Journal of pharmacology and experimental therapeutics 20090901

• A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.

  BJU international 20040601

• A randomized crossover study to evaluate Ro 115-1240, a selective alpha-adrenoceptor partial agonist in women with stress urinary incontinence.

  BJU international 20040501

• A randomized crossover study to evaluate Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.

  BJU international 20040101

• Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence.

  BJU international 20040101